期刊文献+

国内外有关结直肠癌肝转移诊治指南要旨及评价 被引量:3

Keystones and evaluation on guidelines of national and international colorectal liver metastases
原文传递
导出
摘要 近年来结直肠癌肝转移的诊治理念不断更新,外科技术发展迅速,临床实践的规范化程度也显著提高,因而病人的生存效果也得以显著改善。多学科综合治疗协作组诊疗模式、分组别诊疗、可切除性评估、R0手术切除、分子检测以及系统性治疗是结直肠癌肝转移相关指南推荐的核心内容。 In recent years, the concept of diagnosis and treatment, development of surgical skill, the standardization of clinical practice have improved significantly. And thus the survival of patients has been improved significantly. Muhidisciplinary team diagnosis and treatment model, sub-group diagnosis and treatment, resectability, molecular testing and systemic treatment are the core contents of guidelines on eoloreetal liver metastases.
出处 《中国实用外科杂志》 CSCD 北大核心 2016年第4期379-382,共4页 Chinese Journal of Practical Surgery
基金 国家临床重点建设专科项目基金[卫办医政函(2012)650号]
关键词 结直肠癌肝转移 指南 多学科综合治疗协作组 可切除性 分子检测 colorectal cancer liver metastases guideline muhidisciplinary team reseetability molecular testing
  • 相关文献

参考文献17

  • 1National Comprehensive Cancer Network. NCCN Clinical Prac- tice Guidelines in Oncology: colon cancer Verson 1.2016. [S/ OL]. [2016-01-01]. http://www.nccn.org/professionals/physi- cian_gls/pdf/colon.pdf.
  • 2National Comprehensive Cancer Network. NCCN Clinical Prac- tice Guidelines in Oncology: rectal cancer Verson 1.2016[S/OL]. [2016-01-01 ]. http://www.nccn.nrg/professionals/physician_gls/ pdf/rectal.pdf.
  • 3Van Cutsem E, Cervantes A, Nordlinger B, et al. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diag- nosis, treatment and follow-up [J]. Ann Oncol, 2014, 25 (suppl 3):iii 1-9.
  • 4许剑民,任黎.结直肠癌肝转移诊断和综合治疗指南(V2013)[J].中国实用外科杂志,2013,33(8):635-644. 被引量:59
  • 5姚宏伟,修典荣,付卫,袁炯,蒋斌,王德臣,马朝来,原春辉,孙涛,石雪迎,马力文,曹宝山,刘剑羽,陈明,陈文,谭石,黄永辉,张莉.多学科协作诊治团队模式治疗可切除的结直肠癌肝转移[J].中华外科杂志,2012,50(11):961-965. 被引量:17
  • 6Cunningham D, Humbler Y, Siena S, et al. Cetuximab monother- apy and cemximab plus irinotecan in irinotecan-refractory meta- slatic colorectal cancer [J]. N Engl J Med, 2004, 351(4): 337-345.
  • 7Hecht JR 1, Mitchell E, Neabauer MA, et al. Lack of correlation between epidermal growth factor receptor status and response to Panitumumab monotherapy in metastatic colorectal cancer [J]. Clin Cancer Res, 2010, 16(7):2205-2213.
  • 8Heinemann V, Modest D, Fischer yon Weikerslhal L, et al. Inde- pendent radiologieal evaluation nf objective response early tumor shrinkage, and depth of response in FIRE-3 (AIO KRK-0306) [J ]. Ann Oncol, 2014, 25(snppl 2): ii117.
  • 9Douillard JY, Oliner KS, Siena S, et al. Panitumumab-FOLF- OX4 treatment and RAS mutations in colorectal cancer [J]. N Engl J Med, 2013, 369(11): 1023-1034.
  • 10Cunningham D, Atkin W, Lenz HJ, et al. Colorectal cancer[J]. Lancet, 2010, 375(9719): 1030-1047.

二级参考文献2

共引文献73

同被引文献11

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部